Speaking at Fall Clinical 2026, Gelfand covered which psoriasis patients may suit GLP-1s and a planned trial of the drugs alone in mild to moderate disease.
Recap by typeshit. Full story at Dermatology Times.
A Facebook post says US researchers found pancreatic cells producing GLP-1 on their own. It frames this as a possible built-in appetite and sugar control system, without naming the study.
Researchers are studying whether GLP-1 drugs, which act on mood, appetite and reward pathways, could help with depression, addiction and binge eating.
A retrospective cohort checks whether retinal disease started or worsened more in established users than in people never on either drug, plus a regional NAION review.
24:34
An animated explainer walking through what semaglutide does in the body, from appetite signals in the brain to digestion and blood sugar control.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
Loading…